Showing 691-700 of 1319 results for "".
Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Case Report: Cerebral Aneurysm Rerupture
https://practicalneurology.com/diseases-diagnoses/stroke/case-report-cerebral-aneurysm-rerupture/31817/Antifibrinolytic therapy may induce cerebral aneurysmal thrombosis that can obscure unstable aneurysms, delaying diagnosis and treatment.Genomics to Gene Therapy in Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/genomics-to-gene-therapy-in-neurology/31565/Recent advances in neurogenomics are changing how we practice neurology.The Whole Physician: Physicians with Substance Use Disorder: Help Is Available
https://practicalneurology.com/columns/practice-management/the-whole-physician-physicians-with-substance-use-disorder-help-is-available/32059/Support is available for physicians with substance use disorder, allowing them to return to health and their profession.Neuropsychiatric Symptoms in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/neuropsychiatric-symptoms-in-dementia/31913/Advances have been made in the management of psychosis, agitation, apathy, and sleep in patients with Alzheimer disease and related disorders.Comorbidity Disparities in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/comorbidity-disparities-in-multiple-sclerosis/31763/Comorbid diseases that are often more prevalent in underserved groups have large effects on multiple sclerosis prognosis.- PQRI: Buy or Sell?https://practicalneurology.com/columns/practice-management/pqri-buy-or-sell/30997/Overview of Pay-for-Performance and the Physician Quality Reporting Initiative in NeurologyIn the September 2008 issue of *Practical Neurology*, Hayward and Kent provide a critical analysis of the Pay-for-Performance (P4P) system, specifically focusing on the Physician Quality Reporting Initiative (
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31366/Latest Advances in Epilepsy Research Highlighted at AES 59th Annual MeetingThe American Epilepsy Society’s 59th Annual Meeting, held in Washington DC from December 2nd to 6th, showcased significant advancements in epilepsy research and clinical practice. Experts from around the globe converged to di
- How to Give an Award-Winning Performancehttps://practicalneurology.com/columns/practice-management/how-to-give-an-award-winning-performance/31183/Medicare’s Physician Quality Reporting Initiative (PQRI) and Its Impact on Neurology PracticesAs the healthcare landscape increasingly embraces the pay-for-performance (P4P) reimbursement model, Medicare’s Physician Quality Reporting Initiative (PQRI) emerges as a pivotal program for neurologists se
- Straight Talk About Incomehttps://practicalneurology.com/columns/practice-management/straight-talk-about-income/31177/In the May 2007 issue of *Practical Neurology*, an extensive survey of neurologists reveals significant insights into the financial landscape of neurology practice. Despite ongoing challenges within the healthcare system, including declining reimbursement rates and increasing administrative burdens,